Company intelligence / Profile preview

Associates of Cape Cod

East Falmouth, Massachusetts, United Statesacciusa.com ↗

Ownership: Private
Employees: ~130
Development stage: Commercial

Overview

Associates of Cape Cod is a global leader in the manufacture and supply of FDA-approved Limulus Amebocyte Lysate (LAL) reagents and related products for the detection of bacterial endotoxins and glucans. Their products are widely used for quality control in pharmaceuticals, biologics, medical devices, compounding pharmacies, dialysis industries, and clinical diagnostics. They also offer contract testing services and have pioneered sustainable recombinant alternatives to traditional LAL tests.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic substancesRecombinant protein (for recombinant cascade reagents)Enzyme-based detection reagents
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Associates of Cape Cod.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Associates of Cape Cod.

Explore the full profile